ABL Secures Two Major NIH Contracts to Accelerate Drug Development for Translational Sciences August 29, 2024 In a significant boost to its role in advancing therapeutic biotechnology, Advanced BioScience Laboratories, [….]
In Conversation with Helen Sabzevari, President & CEO of Precigen A desire to end disease has taken her from a childhood in Iran to the Scripps Institute, to the NIH [….]
Artificial Intelligence: Reshaping 3Rs Principles for a More Ethical Research This article originally appeared in PQE Group‘s Blog. The post was written by Leonardo Giraudo, Pharmacovigilance Compliance Expert and Marco [….]
Kymanox Announces Evan Edwards as President Morrisville, North Carolina USA, May 06, 2024 (GLOBE NEWSWIRE) — Kymanox®, a leading provider of product development, engineering, quality, regulatory and technical solutions exclusively serving the [….]
Barinthus Bio Names Experienced Physician, Leon Hooftman, M.D., as Chief Medical Officer Dr. Hooftman brings more than 25 years’ experience in international drug development including immunology, autoimmunity, hematology, oncology and [….]
Discover the latest advancements in biomarkers at the 8th Annual Biomarker & Precision Medicine US Congress. Join experts from global pharma, top biotechs, and renowned academic institutions to explore emerging [….]
The Festival of Genomics and Biodata is returning to Boston! Join us on Wednesday, June 12th – Thursday, June 13th, 2024, at the Boston Convention & Exhibition Center for inspirational [….]
Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine
Synexa Life Sciences (Synexa), a global leader in clinical biomarker and bioanalytics research services, recently secured 5,000 square feet of lab space in Rockville, Maryland. The new lab will be located within Inotiv, Inc.’s (Inotiv) Rockville site and is part of a new partnership between Synexa and Inotiv, a leading contract research organization.
Altasciences today announced the continued expansion of their formulation, manufacturing, and analytical services facilities in Philadelphia, PA. Altasciences, an integrated drug development solution company offering pharmaceutical and biotechnology companies worldwide a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services, launched a second building project to increase its capacity and meet the ever-growing needs of its clients.
